Main Street Capital (MAIN) Tops Q2 EPS by 1c
4:06 PM ET, 08/06/2015 - StreetInsider
Main Street Capital (NYSE: MAIN) reported Q2 EPS of $0.55, $0.01 better than the analyst estimate of $0.54.
Herbalife Ltd. Announces Second Quarter 2015 Results and Raises Full Year Guidance
Second quarter adjusted1 EPS of $1.24 per diluted share exceeded guidance of $1.05 - $1.15; reported EPS of $0.97 per diluted share
Raises FY’15 adjusted diluted EPS guidance to a range of $4.50 to $4.70; up from previous range of $4.30 to $4.60
Reported worldwide net sales of $1.2 billion declined 11% due to unfavorable impact of currency exchange rates; net sales excluding currency impact grew 1% compared to prior year period
Cash flow from operations of $197.6 million increased 26% compared to prior year period
ARIAD Pharma (ARIA) Posts Q2 Loss of 33c/Share; Updates FY15 Outlook
7:36 AM ET, 08/05/2015 - StreetInsider
ARIAD Pharma (NASDAQ: ARIA) reported Q2 EPS of ($0.33), $0.06 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $33.24 million. Financial Guidance for 2015Our guidance for revenues from sales of Iclusig remains unchanged. We expect Iclusig revenues for 2015 to be in the range of $130 million to $140 million.We now expect total R&D expenses for 2015 to be in the range of $177 million to $183 million, compared to our previous guidance of $185 million to $195 million. The decrease in R&D expenses is primarily attributable to a reclassification in our forecast of certain expenses from R&D to SG&A to be consistent with our financial-statement classification of such expenses.Additionally, we expect total SG&A expenses for 2015 to be in the range of $166 million to $172 million, compared to our previous guidance of $135 million to $145 million for 2015. The increase in SG&A expenses is primarily attributable to the above-noted reclassification of certain expenses, as well as legal and consulting costs associated with this year s proxy and related initiatives ($6.7 million), and severance and related costs associated with the retirement of our chief executive by year-end ($7.5 million), all of which are non-recurring expenses.As a result of the revised R&D and SG&A guidance and the $50 million in funding received from PDL BioPharma, Inc. in July 2015 pursuant to a synthetic-royalty financing, we expect our cash and cash equivalents at December 31, 2015 to be at least $240 million.
MGM Resorts (MGM) Tops Q2 EPS by 6c
8:04 AM ET, 08/04/2015 - StreetInsider
MGM Resorts (NYSE: MGM) reported Q2 EPS of $0.17, $0.06 better than the analyst estimate of $0.11. Revenue for the quarter came in at $2.39 billion versus the consensus estimate of $2.38 billion.
Key results for the second quarter of 2015 include the following:Net revenue at the Company's wholly owned domestic resorts was $1.7 billion, an increase of 4% compared to the prior year quarter;Rooms revenue at wholly owned domestic resorts increased 6% with a 6% increase in REVPAR(1) at the Company's Las Vegas Strip resorts compared to the prior year quarter;The Company's wholly owned domestic resorts earned Adjusted Property EBITDA(2) of $458 million, an 11% increase compared to the prior year quarter;Adjusted Property EBITDA margin for wholly owned domestic resorts increased 158 basis points to 26.9% in the current year quarter;MGM China's net revenue was $557 million and Adjusted EBITDA was $132 million, decreases of 33% and 37%, respectively, compared to the prior year quarter; andCityCenter's Adjusted EBITDA related to resort operations was $84 million, a 4% increase compared to the prior year quarter.
"We are continuing to drive increased profits at MGM Resorts with second quarter wholly owned Adjusted Property EBITDA up 11% driven by growth at our Las Vegas and regional resorts. These resorts are continuing to gain operating momentum while we continue to make significant progress on our development pipeline in Cotai, Maryland, and Massachusetts," said Jim Murren, Chairman & CEO of MGM Resorts International. "We are focused on positioning the Company for future growth, and are pleased to announce the implementation of our Profit Growth Plan to further enhance our business practices and profitability."
The company is making money again — second quarter operating revenue was $1.258 billion and operating income was $56.9 million, versus revenue of $1.318 billion and operating income of $20.0 million a year earlier.
YRC Worldwide (YRCW) Tops Q2 EPS by 55c
4:20 PM ET, 07/30/2015 - StreetInsider
YRC Worldwide (NASDAQ: YRCW) reported Q2 EPS of $0.80, $0.55 better than the analyst estimate of $0.25. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.31 billion